Intratympanic gentamicin in monolateral Meniere's disease: Our experience

European Archives of Oto-Rhino-Laryngology

Volumn 263, Issue 3, 2006, Pages 271-275

  Bertino, Giulia ^a   Durso, Domenico ^a   Manfrin, Marco ^a   Casati, Luca ^a   Mira, Eugenio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Intratympanic gentamicin; Meniere's disease; Vertigo

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; CLINICAL PROTOCOL; DEPRESSION; EXPERIENCE; FEMALE; HEARING; HUMAN; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; NYSTAGMUS; OTOTOXICITY; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; TITRIMETRY; VERTIGO; VESTIBULAR DISORDER; VESTIBULAR FUNCTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; EAR, MIDDLE; FEMALE; GENTAMICINS; HUMANS; INJECTIONS; MALE; MENIERE DISEASE; MENIERE'S DISEASE; MIDDLE AGED; TREATMENT OUTCOME; VERTIGO;

EID: 33646460612     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-005-0988-0     Document Type: Article

References (33)

1. Aran JM, Dulon D, Hiel H, Erre JP, Aurousseau C (1993) L'ototoxicité d'aminoglicosides: résultats récents sur la captation et la clairance de la gentamicine par les cellules sensorielles du limacon osseux. Rev Laryngol Otol Rhinol (Bord) 114:125-128
2. Atlas JT, Parnes LS (1999) Intratympanic gentamicin titration therapy for intractable Meniere's disease. Am J Otol 20:257-263
3. Beck C, Schimdt CL (1978) Ten years experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 221:149-152
4. Black FO, Pesznecker S, Stallings V (2004) Permanent gentamicin vestibulotoxicity. Otol Neurotol 25:559-569
5. Blakley BW (2000) Update of intratympanic gentamicin for Meniere's disease. Laryngoscope 110:236-240
6. Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 25:544-552
7. Committee on Hearing and Equilibrium of the American Academy of Otolaryngology Head and Neck Surgery (1995) Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 113:181-185
8. Conlon BJ, Gibson PR (1999) Meniere's disease: the incidence of hydrops in the controlateral asymptomatic ear. Laryngoscope 109:1800-1802
9. Driscoll CLW, Kasperbauer JL, Facer GW, Harner SG (1997) Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results. Laryngoscope 107:83-89
10. Fowler E (1948) Streptomycin treatment of vertigo. Trans Am Acad Ophtalmol Otolaryngol 52:239-301
11. Harner SG, Driscoll CLW, Facer GW, Beatty CW, McDonald TJ (2001) Long-term follow-up of transtympanic gentamicin for Menière's syndrome. Otol Neurotol 22:210-214
12. Hirsch BE, Kamerer DB (1997) Intratympanic gentamicin therapy for Meniere's disease. Am J Otol 18:44-51
13. Hoffman F, Beck, C Beck C, Stratulat S (1993) Subablative gentamicin therapy in Meniere's disease. HNO 41:296-300
14. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB (2000) Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Laryngoscope 110:1298-1305
15. Kumar A (1981) Diagnostic advantages of the Torok monothermal differential caloric test. Laryngoscope 91:1678-1694
16. Lange G, Maurer J, Mann W (2004) Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 114:102-105
17. Leone CA, Mosca F, Mincione A (2000) La terapia ablativa con gentamicina nel trattamento della malattia di Menière. Acta Otorhinolaryngol Ital 20:322-329
18. Longridge NS, Mallison AI (2000) Low-dose intratympanic treatment for dizziness in Meniere's disease. J Otolaryngol 29:35-39
19. Lundquist PG, Wersall J (1967) The ototoxic effect of gentamicin - an electron microscopic study. In: Gentamicin. First International Symposium. Schwabe, Basel, pp 26-46
20. Magnusson M, Padoan S (1991) Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Rationale for extremely low dose therapy. Acta Otolaryngol (Stockh) 111:671-676
21. Minor LB (1999) Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 20:209-219
22. Nedzelski JM, Bryce GE, Pfleiderer AG (1992) Treatment of Meniere's disease with topical gentamicin: a preliminary report. J Otolaryngol 21:95-101
23. Odkvist LM, Bergholtz LM, Lundgren A (1984) Topical gentamicin treatment for disabling Meniere's disease. Acta Otolaryngol (Stockh) [Suppl] 412:74-76
24. Pender D (1985) Gentamicin tympanoclisis: effects on the vestibulary secretory cells. Am J Otolaryngol 6:358-367
25. Quaranta A, Scaringi A, Aloisi A, Quaranta N, Salonna I (2001) Intratympanic therapy for Meniere's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol (Stockh) 121:387-392
26. Rudnick MD, Ginsberg IA, Huber PS (1980) Aminoglycoside ototoxicity following middle ear injection. Ann Otol Rhinol Laryngol 89 [Suppl 779]:1-9
27. Rybak LP (1986) Ototoxic mechanism. Neurobiology of hearing. Raven Press, New York, pp 441-454
28. Schuknecht HF (1957) Ablation therapy in the management of Meniere's disease. Acta Otolaryngol (Stockh) [Suppl] 132:1-42
29. Stokroos R, Kingma H (2004) Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Meniere's disease: a prospective, double blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol (Stockh) 124:172-175
30. Thai-Van H, Bounaix MJ, Fraysse B (2001) Meniere's disease. Pathophisiology and treatment. Drugs 61:1089-1102
31. Tran Ba Huy P, Bernard P, Schacht J (1986) Kinetics of gentamicin uptake and release in the rat: comparison of inner ear tissue and fluids with other organs. J Clin Invest 77:1492-1500
32. Williams SE, Zenner H, Schacht J (1987) Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear Res 30:11-18
33. Youssef TF, Poe DS (1998) Intratympanic gentamicin injection for the treatment of the Meniere's disease. Am J Otol 19:435-442